Skip to main content
Premium Trial:

Request an Annual Quote

Great Basin STEC Test Gets FDA 510(k) Clearance

NEW YORK (GenomeWeb) – Great Basin Scientific said today that its Shiga Toxin Direct Test has received 510(k) clearance from the US Food and Drug Administration.

The PCR-based test is designed to detect Shiga toxin-producing Escherichia coli (STEC) and serotype O157 directly from patient specimens. Specifically, the assay detects the stx1 and stx2 genes.

The assay runs on the Great Basin Analyzer, which offers sample-to-answer testing with less than one minute of hands-on time and without a specimen enrichment step. The platform also performs the company's commercially available tests for Clostridium difficile and Group B Streptococcus, and will run the firm's multiplex Staph ID/R Blood Culture Panel, which is pending FDA 510(k) clearance.

"By offering the only direct-from-patient specimen test, and identifying the O157 strain and quickly detecting stx1 and stx2 genes, we are providing clinicians a powerful tool to provide a better outcome for their patients," Great Basin Co-founder and CEO Ryan Ashton said in a statement. "The clearance of this test is particularly timely given the growing number of multistate outbreaks for [STEC O157] infections."

Earlier this month Great Basin reported a 37 percent year-over-year increase in fourth quarter revenues due to the initial adoption of its Group B Strep test, but reported a net loss of $18.9 million compared to a net income of $1.5 million in the same quarter last year.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.